WENCO-INTERNATIONAL
14.9.2022 05:01:37 CEST | Business Wire | Press release
Wenco International Mining Systems Ltd. ("Wenco") is pleased to expand its sales and support to customers in Northern Europe through its new partnership with Rotator Oy, a leading provider of mining equipment and solutions, based in Finland.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220913006133/en/
This new agreement extends Wenco’s reach with a capable value-added reseller, paving the way for customers in the region to further leverage Wenco’s open and interoperable approach to mining technology.
Wenco is a leading provider of technology solutions to the global mining industry with a comprehensive suite of digital solutions that boost productivity, decrease operating costs, extend equipment life, enhance safety, and give mining companies actionable insights into their operations. Mines realize these benefits through systems for fleet management, machine guidance, safety, and asset health — all grounded in an open systems philosophy that empowers them to freely integrate systems to support their unique business processes, data requirements, and reporting needs.
“We’re very positive about the establishment of this partnership with Rotator,” says Andrew Pyne, President and CEO of Wenco. “They have a very strong presence in the region and an excellent track record of sales and support for Hitachi Construction Machinery, our parent company. We’re looking forward to working closely with Rotator to deliver value through the application of our technologies to their customers in the region.”
Rotator CEO Janne Wartiovaara concurs with Pyne. “We are excited to add Wenco to our Mining offering and look forward to bring more valuable solutions to our customers,” says Janne Wartiovaara.
In addition to solutions for fleet operations, Rotator and Wenco are introducing innovative fatigue management solutions to the market with Wenco’s SmartCap, the only technology proven to eliminate safety incidents caused by fatigue. SmartCap uses EEG to measure operator fatigue, then notify users of reduced ability to resist sleep — before a fatigue-related incident occurs.
Wenco and Rotator formed this partnership due to their shared focus on delivering customer-centric solutions to the mining industry. Founded in 1954, Rotator is one of the most experienced and well-established machine import and after-sales service companies in Finland. Located in Pirkkala with satellite offices in Vantaa, Kuopio, Seinäjoki, Oulu, Rovaniemi, Sotkamo, and Lieto, Rotator is committed to providing reliable, efficient, and safe solutions to customers through Finland and Sweden.
The company’s rich history of support for customers made it a natural partner for Wenco in Northern Europe.
Rotator is now in discussions with mines across Finland and Sweden on how they can advance their digital transformation with Wenco’s solutions. To learn more, please contact Rotator Sales Manager Sami Laitila at sami.laitila@rotator.fi or +35840-8242-495. For all other inquiries into Wenco and its solutions, please contact Wenco Regional Manager Europe, Middle East, and Kazakhstan, Klaus Hansson at khansson@wencomine.com or +971-522-600-596.
About Wenco International Mining Systems
For over 30 years, Wenco International Mining Systems has worked with mining companies to extract unrealized value. In support of this mission, Wenco has developed an integrated suite of solutions to support the digital transformation of the mining industry. Fleet management, asset health, fatigue management, and other technologies join together in the spirit of open interoperability to raise mine productivity and efficiency, lower routine costs, and establish a safe and smooth mining operation.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220913006133/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press release
FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 17:00:00 CEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 16:13:00 CEST | Press release
In a head-to-head benchmark, a leading general-purpose LLM was confidently wrong 35% of the time on regulatory dates. Archer Evolv™ shipped zero errors. For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and mo
Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™30.6.2026 16:08:00 CEST | Press release
Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an Investigational New Drug (IND) application for Fizurex™ to the FDA in Q3 2026. Fizurex™, a patent-pending, single-use topical wipe, was designed to provide a standardized, accessible treatment option for a painful and often undertreated medical condition. The product builds on years of use through compounding pharmacy prescriptions and is now advancing toward clinical development and regulatory review. "We are proud to have supported Steel Therapeutics with the generation of the high-quality safety d
Interactive Brokers Expands Access to Korean Equities with Launch of Nextrade ATS30.6.2026 16:00:00 CEST | Press release
IB SmartRouting℠ Routes Orders to the Best Available Price Between KRX and Nextrade Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced the launch of select Korean equities through Nextrade, South Korea's first Alternative Trading System (ATS). The addition of Nextrade builds on Interactive Brokers' earlier launch of the Korea Exchange (KRX), through which it became the first major US-based broker to provide global investors with direct access to Korean equities. Clients trading on Nextrade benefit from significantly extended trading hours and access to additional liquidity. Interactive Brokers has enabled IB SmartRouting℠ across both the Korea Exchange (KRX) and Nextrade, automatically routing orders to the venue offering the best price. This helps clients achieve best execution while providing greater flexibility and more opportunities to participate in one of Asia's most dynamic equity markets. Korea's equity market ranks among the top global exchanges by
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom